Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (59 ops.)
Latest filing published 04 May 2026 for Vir Biotechnology, Inc., €188k. Read the official filing
Filing timeline
BuySaleVicki l. Sato
Insider track record
Disclosed buys
0
Disclosed sells
59
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Vicki l. Sato: trading record in brief
Vicki l. Sato is a declared insider at 3 companies (board member); the most frequent names are Vir Biotechnology, Inc., Denali Therapeutics Inc. and Allogene Therapeutics, Inc. Between 19 May 2021 and 1 May 2026, the trades on record add up to 73 filings.
Every open-market trade on record is a sale: 59 sales worth €11.0M. Outside the open market, there are 13 share grants and 1 option exercise. In 2026 alone, the filings show no purchases and 5 sales.
The newest entry dates from 4 May 2026: an open-market sale of €188k, in Vir Biotechnology, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Vicki l. Sato
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations73 total
22,000 shares@ US$10.04660.022% mcap2.1% of flowCommon StockSEC:0001628280-26-029640:0
22,000 shares@ US$9.07350.020% mcap1.9% of flowCommon StockSEC:0001628280-26-022971:0
21,800 shares@ US$9.50391.7% of flowCommon StockSEC:0001628280-26-013630:0
42,377 shares@ US$1.4850.5% of flowCommon StockSEC:0001628280-26-012397:0
22,000 shares@ US$7.71230.017% mcap1.6% of flowCommon StockSEC:0001628280-26-004866:0
22,000 shares@ US$5.92650.013% mcap1.2% of flowCommon StockSEC:0001628280-26-000320:0
22,000 shares@ US$6.00320.014% mcap1.2% of flowCommon StockSEC:0001628280-25-054884:0
22,000 shares@ US$5.63851.1% of flowCommon StockSEC:0001628280-25-048624:0
22,000 shares@ US$5.83620.013% mcap1.2% of flowCommon StockSEC:0001628280-25-043567:0
22,000 shares@ US$4.99141.0% of flowCommon StockSEC:0001197020-25-000005:0
22,000 shares@ US$4.98631.0% of flowCommon StockSEC:0001628280-25-037344:0
22,000 shares@ US$5.10031.0% of flowCommon StockSEC:0001628280-25-034055:0
8,000 shares0Common StockSEC:0001628280-25-028900:0
10,960 shares@ US$12.521.0% of flowCommon StockSEC:0001628280-25-000994:0
3,080 shares@ US$20.915.0% of flowCommon StockSEC:0001714899-25-000001:0
1,020 shares@ US$30.002.3% of flowCommon StockSEC:0001714899-24-000217:0
3,080 shares@ US$27.076.1% of flowCommon StockSEC:0001714899-24-000208:0
1,020 shares@ US$30.002.2% of flowCommon StockSEC:0001714899-24-000199:0
2,980 shares@ US$24.995.4% of flowCommon StockSEC:0001714899-24-000198:0
2,980 shares@ US$22.124.9% of flowCommon StockSEC:0001714899-24-000155:0
61,475 shares0Common StockSEC:0001593968-24-000839:0
5,967 shares0Common StockSEC:0001714899-24-000138:0
8,000 shares0Common StockSEC:0001628280-24-026217:0
1,674 shares@ US$20.392.5% of flowCommon StockSEC:0001714899-24-000122:0
1,666 shares@ US$18.292.3% of flowCommon StockSEC:0001714899-24-000104:0
25 of 73 declarations
